Page 8 - 2013FallSale

This is a SEO version of 2013FallSale. Click here to view full version

« Previous Page Table of Contents Next Page »
Page 8
The Willner Window Product Reference Catalog, Winter 2014
since 1911
• Willner Chemists •
the nutritional supplement professionals
Adaptogen Complex
Adaptogen Complex
An excellent anti-stress formula; A Chi or energy tonic.
Who would benefit from this supplement? Those suffering from
fatigue, overexertion, stress, chemotherapy, depression. Best used on
a daily basis.
Phyto-Tech™ Adaptogen Complex contains the following herbs:
Red Reishi Mushroom, Eleuthero Root, Ashwagandha Root, Vanuatu
Kava Root, Licorice Root.
Complimentary Formulas: Phyto-Tech Ginseng Energy Blend;
Phyto-Tech Immune Complex
1 fl oz - Prod Code: 57083
Adrenal Stress Complex
Adrenal Stress Complex
Supports healthy adrenal gland function, optimizing the body’s
handling of stress.
Phyto-Tech Adrenal Stress Complex is a blend of adrenal-normaliz-
ing, adaptogenic herbs especially valuable for those suffereing the
stressful effects of a fast paced lifestyle. This formula can be consid-
ered an "adrenal tonic."
This formula also helps maintain healthy blood sugar levels by sup-
porting liver function.
Who would benefit from this supplement? Those suffering from
stress related to a fast-paced, demanding lifestyle. Those who have
problems with blood sugar regulation, including hypoglycemia and
adult onset, type 2 diabetes. Those with adrenal dysfunction leading
to blood sugar swings, water imbalance, mood swings, and thyroid
dysfunction.
Phyto-Tech™ Adrenal Stress Complex contains the following herbs:
Licorice Root, Eleuthero Root, Devil’s Club Root Bark, Dandelion
Root, Sarsaparilla Root, Ginger Root.
Dosage: 20-40 drops in water or juice, 2-3 times daily, or as need-
ed.
Complimentary Formulas: Phyto-Tech Adaptogen Complex, when
fatigue and burn out present
Phyto-Tech Ginseng Energy Blend, when extreme fatigue, low pas-
sion present
Phyto-Tech Holy Basil 20-8-8-5 liquid veggie caps to counteract
stress and control cortisol levels.
1 fl oz - Prod Code: 57037
Allergy Complex
Allergy Complex
This supplement supports healthy sinus and respiratory systems
function by exerting an anti-histamine, decongestant type action.
Who would benefit from this supplement? Those suffering from
allergic rhinitis, hay fever, asthma, and sinus congestion.
Phyto-Tech™ Allergy Complex contains the following herbs:
Nettle Leaf, Eyebright Herb, Yerba Santa Leaf, Turmeric Root, Lobelia
Herb, Ambrosia Herb.
Dosage: Preventative: Begin use 2-4 weeks before the onset of the
allergy season by taking Allergy Complex 2 times per day. This will
increase resistance to pollens before they even start. Keep taking
throughout the allergy season. Results can vary from a percentage
decrease in reactivity to complete eradication of symptoms.
Complimentary Formulas: Many herbalists feel that allergies are a
symptom of liver deficiency, and recommend taking Phyto-Tech Liver
Support along with Allergy Complex.
Eyebright, Nettle and Ambrosia are anti-histamine in action. Yerba
Santa helps decongest. Tumeric treats liver deficiency which almost
all hay fever is a symptom of. By treating the underlying constitution-
al predisposition, Phyto-Tech Allergy Complex can work deeper.
(Note: Ambrosia is also known as ragweed. The leaf extract
inhibits histamines caused by the pollen of this plant. One is not
allergic to the leaf)
1 fl oz - Prod Code: 56983 ~ Alcohol Free: Code 57041
Child Friendly: Code 57013
American Ginseng
American Ginseng
American Ginseng is an adaptogenic, immune-system modulating
herb, enhancing stamina and energy.
Who would benefit from this supplement? Those who are begin-
ning to notice the signs of aging. Those who feel depleted and are
low on passion or vital energy. Those who fear working too hard and
burning out. Those who feel that they are under too much stress,
and it is affecrting their general health. Those who participarte in
athletics, and want to boost energy and stamina. Those who want to
fight the aging process. Those who are elderly, and feel rundown
and mildly depressed.
Description: Phyto-Tech™ American Ginseng 1:3 contains certified
organic American Ginseng (Panax quinquefolium), 333 mg/ml. Also
available in a vegetarian capsule form. Each Phyto-Tech American
Ginseng veggie cap contains 400 mg of certified organic American
Ginseng Root.
American Ginseng is a classic adaptogen herb with systemic
action. It increases resistance to illness and environmental stresses,
improving vigor, vitality, and energy.
American Ginseng does not treat disease directly, but strengthens
the body's ability to adapt to stress and therefore may help to avoid
acute episodes from manifesting when one is dealing with a chronic
disease.
American Ginseng is especially helpful during the later stages in
life, the effects of years of stress, wear and tear on the body begin to
manifest themselves.
Dosage: 20-40 drops, 2-3 times per day It is best used as a long
term tonic (1-3 months and longer).
Complimentary Formulas: For the elderly, Phyto-Tech Ginkgo
Biloba Leaf 1:1.5 works well with American Ginseng, especially if
mild depression is a problem.
American Ginseng 1:3 - 1 fl oz ~ Prod Code: 56981
60 Veggie Caps - Prod Code: 60122
Antiox Phyto Blend
Antiox Phyto Blend
Some of the most powerful, broad-spectrum antioxidants are
those found in plants. This supplement contains a blend of
several of the most potent plant-derived phyto-antioxidants
available, in a convenient liquid extract.
Who might benefit from this supplement? Anyone needing antioxi-
dant protection as well as those looking for enhanced immunity,
those with cardiovascular problems, stress, and concerns about envi-
ronmental pollution. It is also an essential component of any “anti-
aging” supplement regimen.
More specifically, this herbal supplement might benefit: Those
who desire protection against everyday toxins--dietary, environmen-
tal and chemical. Those with current health problems, those under
high amounts of stress, smokers or those exposed to second-hand
smoke, and anyone who lives or is exposed to a toxic lifestyle. Those
who are at risk to the various degenerative diseases associated with
aging, including cancer, cardiovascular disease, cognitive impair-
ment, Alzheimer’s disease, immune dysfunction, cataracts, and mac-
ular degeneration. Those who want to live a longer, healthier life.
Phyto-Tech Antiox Phyto Blend is a mixture of powerful plant-
derived (phyto) antioxidants. Most health problems are either direct-
ly or indirectly related to oxidative (free-radical) damage. While vita-
mins and minerals (vitamin C, vitamin E and selenium, for example)
are antioxidants, it is now recognized that phytoantioxidants, rich in
a broad spectrum of flavonoids, polyphenols, anthocyanidins, etc are
the most powerful.
Phyto-Tech™ Antiox Phyto Blend contains the following: Acai
Berry 4:1, Mangosteen Extract, Goji Berry Extract, Pomegranate
40%, Glycerin Vegetable, Water Pure Deionized, Raspberry Flavor
Natural.
References: Acai Berry (Euterpe oleraceae) is the fruit of a palm
tree native to South America. The pulp and skin of acai are rich in
. . . continued on page 14
Important Notice: The information given here is designed to help you make informed decisions about your health, and the proper use of dietary supplements. It is
not intended as a substitute for medical advice, nor a substitute for any treatment that may have been prescribed by your doctor. If you have a medical problem, you
should seek medical help. Products described herein are not intended to diagnose, treat, cure or mitigate disease.
Product Reference Guide: Willner Chemists Phyto-Tech™ Herbal Supplements
Do The New Guidelines For
Statins Make Sense?
by Dr. Michael Murray
Introduction
The American Heart Association (AHA) and
American College of Cardiology (ACC)
released four new guidelines dealing with the
prevention of cardiovascular disease (CVD)
by better assessing risk and by managing cho-
lesterol, lifestyle, and weight.
The big news is that doctors are now being
urged to move away from specific targets for
cholesterol and instead focus on clinical
assessment of risk.
Unfortunately, the misguided recommenda-
tion will be to increase the focus on prescrib-
ing statins. Under the current guidelines,
statins are recommended for about 15 per-
cent of adults. With the new guidelines 44
percent of men and 22 percent of women
would meet the criteria for taking a statin.
The answer to the question “Do the New
Guidelines for Statins Make Sense” is yes
only if the criteria is providing further big
profits to the drug industry. Honestly, I think
more than anything the new guidelines are
an acknowledgement of the failure of statins
to produce an increase in life expectancy for
75% of the patients the drugs are being pre-
scribed to.
In my opinion, increasing the number of
Americans being prescribed statins will only
increase the number of people these drugs
will provide absolutely no benefit to and like-
ly further increase the problem of statin-
induced side effects.
Background Data:
There is no question that elevated choles-
terol and triglyceride levels greatly increase
the risk of death due to cardiovascular dis-
ease (CVD). Yet while the drug companies
would like us all believe that it’s as simple as
taking a statin drug to reduce your risk of a
heart attack or stroke, it’s just not that sim-
ple. Cholesterol-lowering statin drugs are sold
primarily under the premise that they will
save lives by lowering cholesterol levels, but
in reality they have not demonstrated an
ability to extend life in over 75% of the
patient population these drugs are currently
prescribed for.
Annual sales of these drugs now exceed
$25 billion. They are a huge profit generator
for the drug companies. Without a doubt the
creation of the statin drug empire is perhaps
the greatest accomplishment of the modern
drug era. But, this is an achievement the
drug companies and doctors should be
ashamed of.
While high cholesterol is an important risk
factor, it is important to note that more than
half of people dying from a heart attack or
stroke have low to normal cholesterol levels.
The drug companies’ and government’s prior
response to this fact is to lower the suggested
target cholesterol levels even further, thereby
effectively casting an even wider net for
potential customers. With the new guide-
lines, it is obvious that the goal is to turn as
many Americans as possible into patients
hooked on statins.
It is very interesting that the majority of the
expert members of the panel that drafted the
new guidelines had either received grants
from or were paid consulting or speakers’
fees by the companies that make some of the
most popular statin drugs.
New Data:
There really is not any new data, but rather
an interpretation of prior data by the
American College of Cardiology/American
Heart Association Task Force on Practice
Guidelines. The conclusion of the review was
to give recommendations that ultimately
focused on four groups of individuals identi-
fied as being strong candidates for statin use:
Individuals with clinical cardiovascular
1
disease.
Individuals with primary elevations of
2
LDL–C =190 mg/dl.
Individuals 40 to 75 years of age with dia-
3
betes.
Individuals without clinical cardiovascular
4
disease or diabetes who are 40 to 75 years of
age with an estimated 10-year cardiovascular
disease mortality risk of 7.5% or higher.
Using a risk calculator developed by the
task force can identify individuals in the last
group. But, this risk calculator has already
come under considerable criticism. In fact,
the entire validity of the calculator has come
under fire as it severely overstates the need
for statins.
The equation considers age, sex, total and
HDL cholesterol, systolic blood pressure,
blood pressure treatment, diabetes, and
smoking.
Commentary:
I do not argue that the medical literature
does show is that in people with a history of
a heart attack, stroke, or current signs and
symptoms of existing CVD (Cardio Vascular
Disease), statins do produce some benefits in
reducing deaths due to a heart attack.
However, large evaluations of studies in peo-
ple without a history of heart attack or stroke
who took statin drugs and lowered their cho-
lesterol have shown they did not live any
longer than the people in the placebo group.
For example, the largest and most thorough
review of statins analyzed 11 clinical trials
involving 65,229 participants and was pub-
lished in the
Archives of Internal Medicine
in June 2010.The analysis provides the most
reliable evidence available on the impact of
statin therapy on all-cause mortality among
high-risk individuals without prior CVD. The
results showed that the use of statin therapy
did not result in reduction in all-cause mor-
tality in these high-risk patients.
These results are consistent with other
quality reviews and call into question the
widespread use of statins not only in high-risk
patients without CVD, but also in patients
with the only risk present being elevated
LDL. About 75% of the prescriptions for
statins are written for people with no clinical
evidence of CVD. Statins have not been
shown to increase life expectancy in these
patients.
. . . continued on page 10